Receptor News and Research

RSS

Discovery may offer a promising new path for the study of multiple sclerosis

A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination – when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts communication between nerve cells.

23 Sep 2021

Review provides a detailed summary of the biochemistry underlying ginsenoside production

Ginseng, a widely popular superfood, has long been used in traditional medicine. The health benefits of ginseng are largely attributed to compounds called ginsenosides, which are present in the roots, stems, and leaves of the plant. Ginsenosides are known to prevent inflammation, diabetes, and cancer, and can also help control blood cholesterol levels and reduce aging.

16 Sep 2021

Scientists devise a strategy to enhance anti-tumor immunity

A synthetic molecular code exhibits the potential of enhancing the response of certain cancer patients to immunotherapy treatments.

15 Sep 2021

RIT scientists uncover new information about the way coronavirus attaches to human cells

Rochester Institute of Technology scientists have uncovered new information about the way coronavirus and several of its variants attach to human cells.

14 Sep 2021

Researchers develop a new method for monitoring organic pollutants using plants

Researchers at Kobe University's Biosignal Research Center have successfully developed plants that can be used to detect organic pollutants, such as polychlorinated biphenyls and endocrine-disrupting chemicals, which contaminate soil and water.

9 Sep 2021

Study details replication and immune evasion of Delta SARS-CoV-2 variant

According to scientists, the Delta variant of SARS-CoV-2 has likely spread through its capability to avoid neutralizing antibodies and its heightened infectivity.

8 Sep 2021

Researchers engineer CAR T cells to enhance their function

Chimeric antigen receptor (CAR) T cell therapy employs engineered T cells to treat certain kinds of cancers.

7 Sep 2021

Family of naturally occurring proteins shows promise for treating ischemic stroke

Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston.

2 Sep 2021

New drug delivery strategy could make it easier for patients to take their medications

In recent years, scientists have developed monoclonal antibodies -; proteins that mimic the body's own immune defenses -; that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn's disease.

31 Aug 2021

Study proposes a novel approach for developing safer analgesics

Opioids are potent painkillers; however, their use is hampered as patients become tolerant to them, necessitating more and more doses.

From The University of California, Davis 31 Aug 2021

Old habit-controlling neurons may also play a key role in learning new tricks

Imagine working on your computer and typing the same long password you have used for years to access your email.

26 Aug 2021

Scientists isolate monoclonal antibodies against alphaviruses

A research group has isolated monoclonal antibodies that, in laboratory and animal studies, prohibited infection by alphaviruses.

From Vanderbilt University 24 Aug 2021

Researchers identify potent antibody that protects against a wide range of viral variants

The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019.

23 Aug 2021

Researchers discover how glycans act as gateways for SARS-CoV-2 entry

Since the early days of the COVID pandemic, scientists have aggressively pursued the secrets of the mechanisms that allow severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter and infect healthy human cells.

From UC San Diego 20 Aug 2021

Researchers develop heat-controllable CAR T cells to kill tumors and prevent relapse

A team of researchers led by bioengineers at the Georgia Institute of Technology is expanding the precision and ability of a revolutionary immunotherapy that is already transforming oncology. CAR T-Cell therapy has been hailed by patients, clinical-researchers, investors, and the media as a viable cure for some cancers.

19 Aug 2021

Receptor News and Research

Discovery may offer a promising new path for the study of multiple sclerosis

Review provides a detailed summary of the biochemistry underlying ginsenoside production

Scientists devise a strategy to enhance anti-tumor immunity

RIT scientists uncover new information about the way coronavirus attaches to human cells

Researchers develop a new method for monitoring organic pollutants using plants

Study details replication and immune evasion of Delta SARS-CoV-2 variant

Researchers engineer CAR T cells to enhance their function

Family of naturally occurring proteins shows promise for treating ischemic stroke

New drug delivery strategy could make it easier for patients to take their medications

Study proposes a novel approach for developing safer analgesics

Old habit-controlling neurons may also play a key role in learning new tricks

Scientists isolate monoclonal antibodies against alphaviruses

Researchers identify potent antibody that protects against a wide range of viral variants

Researchers discover how glycans act as gateways for SARS-CoV-2 entry

Researchers develop heat-controllable CAR T cells to kill tumors and prevent relapse

New gene activity sensors, activators could help treat diabetes, cancer, and other disorders

Study pinpoints genes responsible for kidney function

Insect olfaction could be used to help develop drug screening techniques

New study could help design more effective vaccines against various COVID-19 variants

Study uncovers key factors immune cells need to survive in the battle against cancer

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics